StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.12−0.09 (-1.45%)

Close on Nov 19, 2026Market cap $369.00MP/E –Yield –

Eupraxia Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?